National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

epothilone KOS-1584
A second-generation epothilone with potential antineoplastic activity. Epothilone KOS-1584 binds to tubulin and induces microtubule polymerization and stabilizes microtubules against depolymerization, which may result in the inhibition of cell division, the induction of G2/M arrest, and apoptosis. Compared to first-generation epothilones, this agent exhibits greater safety and efficacy with an enhanced pharmaceutical profile, including enhanced water solubility and tumor penetration, and reduced CNS exposure. In addition, epothilone KOS-1584 is a poor substrate for the P-glycoprotein (P-gp) drug efflux pump. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:KOS-1584
Chemical structure name:9,10-didehydroepothilone D



Previous:epoetin alfa, epoetin beta, Epogen, epothilone B, epothilone D
Next:epothilone ZK-219477, epratuzumab, Eprex, erastin analogue PRLX 93936, Eraxis

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov